SWOG clinical trial number
SWOG-9433 (CALGB-9331)
A Phase II Feasibility Study of High Dose Cyclophosphamide, Cisplatin and Carmustine (CBP) Therapy as Consolidation for Patients with Limited Small Cell Lung Cancer (SCLC) in or Near Complete Response to Chemotherapy
Closed
Phase
Abbreviated Title
A Phase II Feasibility Study of High Dose Cyclophosphamide, Cisplatin and Carmustine (CBP) Therapy as Consolidation for Patients with Limited Small Cell Lung Cancer (SCLC) in or Near Complete…
Activated
12/15/1994
Closed
03/31/1997